Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 270

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 270
---
 Acquired Contract Intangible Asset During the year ended December 31, 2022, we recorded a $3.7 million impairment charge to reduce the carrying value of the intangible asset to its fair value of zero, based on a formal notice of termination we received on April 25, 2022 from Gossamer for the Gossamer License Agreement (as defined in Note 5 to the consolidated financial statements). The Gossamer License Agreement terminated effective July 24, 2022. Based on the Notice of Termination, we fully impaired the intangible asset during the nine months ended September 30, 2022, as the Gossamer License Agreement is the sole underlying asset. In connection with the termination of the Gossamer License Agreement, the CVR Agreement (as defined in Note 5 to the consolidated financial statements), pursuant to which the contingent value rights (“CVRs”) were issued to legacy holders of common stock of Aerpio immediately prior to the Merger, automatically terminated in accordance with its terms and the CVRs were automatically cancelled and forfeited without any consideration or payment, in each case effective July 24, 2022. Other Income (Expense), Net The following table sets forth our other income, net:

|                         |     | Year Ended   
 December 31, |  2023 |   |     |   |  2022 |   |
|:------------------------|:----|:-------------|------:|:--|:----|:--|------:|:--|
| Foreign exchange loss   |     |              |    (1 | ) |     |   |     — |   |
| Interest income         |     |              | 6,400 |   |     |   | 2,398 |   |
| Interest expense        |     |              |  (231 | ) |     |   |  (230 | ) |
| Total other income, net |     | $            | 6,168 |   |     | $ | 2,168 |   |

- 188 -

Other income, net for the year ended December 31, 2023, was $6.2 million of income, compared to
$2.2 million of income for the year ended December 31, 2022. The change was primarily driven by higher interest rates on short-term investments held during the year ended December 31, 2023 compared to the year ended December 31,
2022.

Liqu